Comparison of Magnesium Sulphate and Dexmedetomidine with Ropivacaine Heavy as its adjuvants, in Spinal Anesthesia for Infra-Umbilical surgeries and Post-operative Analgesia

Comparison of Dexmedetomidine and Magnesium Sulphate as Adjuvant with Ropivacaine Heavy in Spinal Anesthesia for Infra-Umbilical surgeries and Post-operative Analgesia - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/063409

Enrollment

Registered

2024-03-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: ROPIVACAINE WITH DEXMEDETOMIDINE AND MAGNESIUM SULPHATE IN SPINAL ANAESTHESIA: ROPIVACAUNE-0.75%,INTRA-THECAL DEXMEDETOMIDINE-10 MICROGRAMS,INTRA-THECAL MAGNESIUM SULPHATE-75MG,INTRA-TH

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 to 60 years of either sex. 2. ASA Grade I and II. 3. Patients undergoing infra-umbilical surgeries under spinal anaesthesia.

Exclusion criteria

Exclusion criteria: 1.Patient unwillingness 2.ASA—Grade III and Grade IV 3.Allergy to given drugs 4.Local site infections 5.Pregnant women 6.Bledding disorders and cardio-pulmonary disorders. 7.Patients with neurological deficits.

Design outcomes

Primary

Measure	Time frame
Post-operative analgesiaTimepoint: 6hrs after each surgery,baseline	—

Secondary

Measure	Time frame
hypotension,bradycardia,vomiting,if any.Timepoint: upto 6-8hrs after surgery,baseline	—

Countries

India

Contacts

Public ContactVANGALA VYSHNAVI

GOVERNMENT MEDICAL COLLEGE,ANANTAPURAMU.

dr_KLS2008@yahoo.in9849014112

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026